Chitomed
Develops and implements innovative technological solutions based on chitosan and microcrystalline chitosan biomaterials for pharmaceutical, medical, and cosmetics industries, specializing in biomaterials for applications like hydrogels in neurosurgery and bone formation.
- CEO / Founder
- Edyta Wątrobińska
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- Undisclosed
- Latest Round
- Crowdfunding
Technology & Products
Key Products
Chitosan-based biomaterials, hydrogels for neurosurgery and bone formation, biomaterials for pharmaceutical, medical, and cosmetics industries.
Technological Advantage
Focus on chitosan biopolymer for medical and cosmetic applications, with expertise in processing technologies developed over many years through scientific cooperation.
Differentiation
Value Proposition
Provides advanced chitosan-based biomaterials that enable rapid and lasting improvements in skin, hair, and medical applications, leveraging interdisciplinary expertise in research and implementation of innovative medical devices.
How They Differentiate
Concentrates on chitosan-based biomaterials rather than traditional 3D printing hardware or software, targeting specific medical and cosmetic applications with a focus on biomaterial innovation.
Market & Competition
Target Customers
Pharmaceutical, medical device, and cosmetics companies
Industry Verticals
Pharmaceutical; Medical; Cosmetics
Competitors
CELLINK; Organovo
Growth & Milestones
Growth Metrics
Establishment of new headquarters in the Netherlands to advance biomaterials R&D and manufacturing; product sales of RegCare creams (e.g., 50 ml jars available for sale); crowdfunding investment indicates financial growth.
Major Milestones
Established new headquarters in Maastricht, Netherlands to advance biomaterials R&D and manufacturing